ZDHHC14
Palmitoyltransferase ZDHHC14
Also known as: FLJ20984, NEW1CP, ZDH14_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q8IZN3
- Gene
- ZDHHC14
- Ensembl
- ENSG00000175048
- Chromosome
- 6
- Canonical length
- 488 aa
- Protein class
- Enzymes, Metabolic proteins, Predicted membrane proteins
- Subcellular location
- Vesicles
OverviewNCBI Gene
Enables palmitoyltransferase activity. Involved in peptidyl-L-cysteine S-palmitoylation. Located in endoplasmic reticulum. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
488 residues, UniProt reviewed canonical sequence.
>Q8IZN3|ZDHHC14
1 MPPGGGGPMK DCEYSQISTH SSSPMESPHK KKKIAARRKW EVFPGRNKFF CNGRIMMARQ
61 TGVFYLTLVL ILVTSGLFFA FDCPYLAVKI TPAIPAVAGI LFFFVMGTLL RTSFSDPGVL
121 PRATPDEAAD LERQIDIANG TSSGGYRPPP RTKEVIINGQ TVKLKYCFTC KIFRPPRASH
181 CSLCDNCVER FDHHCPWVGN CVGKRNYRFF YMFILSLSFL TVFIFAFVIT HVILRSQQTG
241 FLNALKDSPA SVLEAVVCFF SVWSIVGLSG FHTYLISSNQ TTNEDIKGSW SNKRGKENYN
301 PYSYGNIFTN CCVALCGPIS PSLIDRRGYI QPDTPQPAAP SNGITMYGAT QSQSDMCDQD
361 QCIQSTKFVL QAAATPLLQS EPSLTSDELH LPGKPGLGTP CASLTLGPPT PPASMPNLAE
421 ATLADVMPRK DEHMGHQFLT PDEAPSPPRL LAAGSPLAHS RTMHVLGLAS QDSLHEDSVR
481 GLVKLSSVLocalizationUniProt · AlphaFold · HPA
Whether an antibody against ZDHHC14 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 4
- Mean surface accessibility (rSASA)
- 0.44
- Highest tissue expression
- 11 nTPM
Expression across tissuesHPA
Tissue
- spinal cord: 11 nTPM
- endometrium: 9.7 nTPM
- cerebral cortex: 6.3 nTPM
- smooth muscle: 5.7 nTPM
- cerebellum: 5.6 nTPM
- parathyroid gland: 5.3 nTPM
Single-cell type
- bergmann glia: 604 nCPM
- oligodendrocyte progenitor cells: 579 nCPM
- distal convoluted tubule cells: 574 nCPM
- lymphatic endothelial cells: 473 nCPM
- erythrocyte progenitors: 404 nCPM
- ependymal cells: 397 nCPM
Immune cell
- plasmacytoid DC: 1.3 nTPM
- memory B-cell: 0.4 nTPM
- MAIT T-cell: 0.2 nTPM
- naive B-cell: 0.2 nTPM
- gdT-cell: 0.1 nTPM
- memory CD4 T-cell: 0.1 nTPM
Brain region
- white matter: 56 nTPM
- spinal cord: 37 nTPM
- medulla oblongata: 35 nTPM
- thalamus: 31 nTPM
- cerebellum: 29 nTPM
- pons: 29 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.42
- gnomAD pLI
- 0.72
- gnomAD missense Z
- 2.24
- DepMap mean gene effect
- 0.03
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ZDHHC14 as an antibody target. Whether an autoantibody or antibody against ZDHHC14 could matter depends on whether native ZDHHC14 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ZDHHC14 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label ZDHHC14 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...